Affinivax Appoints Stuart Chaffee, PhD, as Main Business Officer | Enterprise & Finance
CAMBRIDGE, Mass.–(Small business WIRE)–Apr 20, 2021–
Affinivax, Inc. (“Affinivax”), a clinical phase biopharmaceutical business pioneering the enhancement of a novel course of vaccines with its MAPS™ (Various Antigen Presenting Technique) system, nowadays declared that Stuart Chaffee, PhD, has joined the corporation as Chief Organization Officer. Dr. Chaffee delivers to Affinivax substantial practical experience in company operations, finance and company enhancement, including previous roles as Main Business enterprise Officer and CFO at Praxis Precision Medications and as Head of Company Functions and Co-founder of Kymera Therapeutics.
Affinivax Main Organization Officer Stuart Chaffee PhD (Photograph: Business Wire)
“We are very happy to welcome Stuart to our management workforce, as he brings a prosperity of monetary, strategic planning and operations skills that will be immensely useful to Affinivax as we choose on the main chances ahead of us,” mentioned Steven Brugger, Main Govt Officer of Affinivax. “Stuart’s strategic capabilities, economical acumen and breadth of awareness throughout drug advancement will guideline our final decision-making as Affinivax continues to progress our novel class of MAPS vaccines to effect human health and fitness.”
“This is an exciting time to join Affinivax as the enterprise makes clinical development with its pipeline of MAPS vaccines, and I am eager to leverage my expertise to assistance the firm achieve its goals as a vaccine innovator,” reported Dr. Chaffee. “I am delighted to be element of a sturdy and completed workforce that is groundbreaking a new tactic to vaccines with the MAPS system that can have an impact on stopping and treating several diseases.”
Stuart Chaffee delivers around 20 yrs of R&D, enterprise and company advancement knowledge to Affinivax. Most not too long ago, Dr. Chaffee served as the Chief Organization Officer and Chief Economic Officer of Praxis Precision Medications. Dr. Chaffee’s business-creating track record in drug discovery and enhancement involves his job as Entrepreneur in Home at Atlas Venture exactly where he was co-founder and Head of Small business Functions at Kymera Therapeutics. Earlier in his career, Dr. Chaffee served in a number of roles at Biogen across Finance, Business enterprise Improvement, Software Leadership, and Corporate Technique. Dr. Chaffee acquired a BS in chemistry from The College or university of William and Mary, a PhD in natural chemistry from Yale University, and an MBA in finance from the Wharton Faculty of the College of Pennsylvania.
Affinivax is a medical stage biopharmaceutical enterprise revolutionary the enhancement of a novel class of vaccines made to induce a broad and sturdy protective immune reaction to both disease-related polysaccharides and disorder-related proteins in a solitary vaccine. Affinivax types each of its vaccine candidates to enhance the protecting immune response to one or both equally of these antigens using the unique plug-and-perform nature of its proprietary MAPS™ platform technological innovation, presenting the probable prospect to make a sizeable step forward in addressing important health care troubles posed by novel and resistant infectious illnesses. Affinivax was founded in 2014 with a seed financial commitment from the Bill & Melinda Gates Foundation and an exclusive license to the MAPS technologies from Boston Children’s Clinic. For additional info, visit www.affinivax.com.
Search phrase: UNITED STATES NORTH America MASSACHUSETTS
Industry Search phrase: BIOTECHNOLOGY INFECTIOUS Illnesses Overall health PHARMACEUTICAL Medical TRIALS
Copyright Enterprise Wire 2021.
PUB: 04/20/2021 08:45 AM/DISC: 04/20/2021 08:45 AM
Copyright Business Wire 2021.
